Raras
Buscar doenças, sintomas, genes...
Deficiência de coenzima Q10
ORPHA:35656CID-11 · 5C53.22DOENÇA RARA

Condição geneticamente heterogênea, tipicamente herdada de forma autossômica recessiva, caracterizada por deficiência de coenzima Q10.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Condição geneticamente heterogênea, tipicamente herdada de forma autossômica recessiva, caracterizada por deficiência de coenzima Q10.

Pesquisas ativas
2 ensaios
6 total registrados no ClinicalTrials.gov
Publicações científicas
180 artigos
Último publicado: 2026 Apr 17

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
41 sintomas
💪
Músculos
12 sintomas
📏
Crescimento
9 sintomas
👁️
Olhos
8 sintomas
❤️
Coração
7 sintomas
🫘
Rins
7 sintomas

+ 52 sintomas em outras categorias

Características mais comuns

Nistagmo horizontal
Hipotonia axial
Anormalidade no EMG
Dor
Impulsividade
Acidúria 2-hidroxiglutárica
156sintomas
Sem dados (156)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 156 características clínicas mais associadas, ordenadas por frequência.

Nistagmo horizontalHorizontal nystagmus
Hipotonia axialAxial hypotonia
Anormalidade no EMGEMG abnormality
DorPain
ImpulsividadeImpulsivity

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico180PubMed
Últimos 10 anos184publicações
Pico202423 papers
Linha do tempo
2026Hoje · 2026🧪 2009Primeiro ensaio clínico📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

9 genes identificados com associação a esta condição. Padrão de herança: Autosomal recessive.

COQ52-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Methyltransferase required for the conversion of 2-decaprenyl-6-methoxy-1,4-benzoquinol (DDMQH2) to 2-decaprenyl-3-methyl-6-methoxy-1,4-benzoquinol (DMQH2)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Ubiquinol biosynthesis
MECANISMO DE DOENÇA

Coenzyme Q10 deficiency, primary, 9

A form of coenzyme Q10 deficiency, an autosomal recessive disorder with variable manifestations consistent with 5 major phenotypes. The phenotypes include an encephalomyopathic form with seizures and ataxia; a multisystem infantile form with encephalopathy, cardiomyopathy and renal failure; a predominantly cerebellar form with ataxia and cerebellar atrophy; Leigh syndrome with growth retardation; and an isolated myopathic form. COQ10D9 patients show cerebellar ataxia with cerebellar atrophy. Additional features include generalized tonic-clonic seizures, and cognitive disability. Disease onset is in the first decade of life.

VIAS REACTOME (1)
OUTRAS DOENÇAS (1)
coenzyme q10 deficiency, primary, 9
HGNC:HGNC:28722UniProt:Q5HYK3
COQ4Ubiquinone biosynthesis protein COQ4 homolog, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Lyase that catalyzes the C1-decarboxylation of 4-hydroxy-3-methoxy-5-(all-trans-decaprenyl)benzoic acid into 2-methoxy-6-(all-trans-decaprenyl)phenol during ubiquinone biosynthesis

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Ubiquinol biosynthesis
MECANISMO DE DOENÇA

Coenzyme Q10 deficiency, primary, 7

An autosomal recessive disorder resulting from mitochondrial dysfunction and characterized by decreased levels of coenzyme Q10, and severe cardiac or neurologic symptoms soon after birth, usually resulting in death. Rarely, symptoms may have later onset.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
spastic ataxia 10, autosomal recessiveneonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome
HGNC:19693UniProt:Q9Y3A0
COQ6Ubiquinone biosynthesis monooxygenase COQ6, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

FAD-dependent monooxygenase required for two non-consecutive steps during ubiquinone biosynthesis (PubMed:26260787, PubMed:38425362). Required for the C5-ring hydroxylation during ubiquinone biosynthesis by catalyzing the hydroxylation of 4-hydroxy-3-(all-trans-decaprenyl)benzoic acid to 3,4-dihydroxy-5-(all-trans-decaprenyl)benzoic acid (PubMed:26260787, PubMed:38425362). Also acts downstream of COQ4, for the C1-hydroxylation during ubiquinone biosynthesis by catalyzing the hydroxylation of 2-m

LOCALIZAÇÃO

Mitochondrion inner membraneGolgi apparatusCell projection

VIAS BIOLÓGICAS (1)
Ubiquinol biosynthesis
MECANISMO DE DOENÇA

Coenzyme Q10 deficiency, primary, 6

An autosomal recessive disorder characterized by onset in infancy of severe progressive nephrotic syndrome resulting in end-stage renal failure and sensorineural deafness. Renal biopsy usually shows focal segmental glomerulosclerosis.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
familial steroid-resistant nephrotic syndrome with sensorineural deafnessschwannomatosis
HGNC:20233UniProt:Q9Y2Z9
COQ8AAtypical kinase COQ8A, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Atypical kinase involved in the biosynthesis of coenzyme Q, also named ubiquinone, an essential lipid-soluble electron transporter for aerobic cellular respiration (PubMed:21296186, PubMed:25498144, PubMed:25540914, PubMed:27499294, PubMed:36302899, PubMed:38425362). Its substrate specificity is still unclear: may act as a protein kinase that mediates phosphorylation of COQ3 (By similarity). According to other reports, acts as a small molecule kinase, possibly a lipid kinase that phosphorylates

LOCALIZAÇÃO

Mitochondrion membrane

VIAS BIOLÓGICAS (1)
Ubiquinol biosynthesis
MECANISMO DE DOENÇA

Coenzyme Q10 deficiency, primary, 4

An autosomal recessive disorder characterized by childhood-onset of cerebellar ataxia and exercise intolerance. Patient manifest gait ataxia and cerebellar atrophy with slow progression. Additional features include brisk tendon reflexes and Hoffmann sign, variable psychomotor retardation and variable seizures.

VIAS REACTOME (1)
OUTRAS DOENÇAS (1)
autosomal recessive ataxia due to ubiquinone deficiency
HGNC:16812UniProt:Q8NI60
PDSS2All trans-polyprenyl-diphosphate synthase PDSS2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Heterotetrameric enzyme that catalyzes the condensation of farnesyl diphosphate (FPP), which acts as a primer, and isopentenyl diphosphate (IPP) to produce prenyl diphosphates of varying chain lengths and participates in the determination of the side chain of ubiquinone (PubMed:16262699). Supplies nona and decaprenyl diphosphate, the precursors for the side chain of the isoprenoid quinones ubiquinone-9 (Q9) and ubiquinone-10 (Q10) respectively (PubMed:16262699). The enzyme adds isopentenyl dipho

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (1)
Ubiquinol biosynthesis
MECANISMO DE DOENÇA

Coenzyme Q10 deficiency, primary, 3

A fatal encephalomyopathic form of coenzyme Q10 deficiency with nephrotic syndrome. Coenzyme Q10 deficiency is an autosomal recessive disorder with variable manifestations consistent with 5 major phenotypes. The phenotypes include an encephalomyopathic form with seizures and ataxia; a multisystem infantile form with encephalopathy, cardiomyopathy and renal failure; a predominantly cerebellar form with ataxia and cerebellar atrophy; Leigh syndrome with growth retardation; and an isolated myopathic form.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
19.3 TPM
Fibroblastos
14.0 TPM
Tireoide
12.8 TPM
Linfócitos
11.8 TPM
Pituitária
11.5 TPM
OUTRAS DOENÇAS (1)
coenzyme Q10 deficiency, primary, 3
HGNC:HGNC:23041UniProt:Q86YH6
PDSS1All trans-polyprenyl-diphosphate synthase PDSS1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Heterotetrameric enzyme that catalyzes the condensation of farnesyl diphosphate (FPP), which acts as a primer, and isopentenyl diphosphate (IPP) to produce prenyl diphosphates of varying chain lengths and participates in the determination of the side chain of ubiquinone (PubMed:16262699). Supplies nona and decaprenyl diphosphate, the precursors for the side chain of the isoprenoid quinones ubiquinone-9 (Q9)and ubiquinone-10 (Q10) respectively (PubMed:16262699). The enzyme adds isopentenyl diphos

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (1)
Ubiquinol biosynthesis
MECANISMO DE DOENÇA

Coenzyme Q10 deficiency, primary, 2

An autosomal recessive multisystem disorder characterized by early-onset deafness, optic atrophy, mild intellectual disability, peripheral neuropathy, obesity, livedo reticularis, and cardiac valvulopathy.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
18.6 TPM
Intestino delgado
10.7 TPM
Cólon transverso
10.5 TPM
Cérebro - Hemisfério cerebelar
10.4 TPM
Fibroblastos
9.2 TPM
OUTRAS DOENÇAS (1)
deafness-encephaloneuropathy-obesity-valvulopathy syndrome
HGNC:17759UniProt:Q5T2R2
COQ7NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the hydroxylation of the 5-methoxy-2-methyl-3-(all-trans-polyprenyl)benzoquinone at the C6 position and participates in the biosynthesis of ubiquinone (Probable). Catalyzes the reaction through a substrate-mediated reduction pathway, whereby NADH shuttles electrons to 5-methoxy-2-methyl-3-(all-trans-decaprenyl)benzoquinone, which then transfers the electrons to the two Fe(3+) centers (PubMed:23445365). The binding of 5-methoxy-2-methyl-3-(all-trans-polyprenyl)benzoquinone (DMQn) mediat

LOCALIZAÇÃO

Mitochondrion inner membraneMitochondrionNucleusChromosome

VIAS BIOLÓGICAS (1)
Ubiquinol biosynthesis
MECANISMO DE DOENÇA

Coenzyme Q10 deficiency, primary, 8

An autosomal recessive disorder resulting from mitochondrial dysfunction and characterized by decreased levels of coenzyme Q10. Patients manifest neonatal lung hypoplasia, contractures, early infantile hypertension and cardiac hypertrophy, secondary to prenatal kidney dysplasia, with neonatal and infantile renal dysfunction. Clinical features also include progressive peripheral neuropathy, muscular hypotonia and atrophy, and mild psychomotor delay with hearing and visual impairment.

VIAS REACTOME (1)
OUTRAS DOENÇAS (4)
primary coenzyme Q10 deficiency 8neuronopathy, distal hereditary motor, autosomal recessive 9encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndromeCOQ7-related distal hereditary motor neuropathy
HGNC:2244UniProt:Q99807
COQ9Ubiquinone biosynthesis protein COQ9, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Membrane-associated protein that warps the membrane surface to access and bind aromatic isoprenes with high specificity, including ubiquinone (CoQ) isoprene intermediates and presents them directly to COQ7, therefore facilitating the COQ7-mediated hydroxylase step (PubMed:25339443, PubMed:30661980, PubMed:38425362). Participates in the biosynthesis of coenzyme Q, also named ubiquinone, an essential lipid-soluble electron transporter for aerobic cellular respiration (PubMed:25339443, PubMed:30661

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (1)
Ubiquinol biosynthesis
MECANISMO DE DOENÇA

Coenzyme Q10 deficiency, primary, 5

A form of coenzyme Q10 deficiency, an autosomal recessive disorder with variable manifestations consistent with 5 major phenotypes. The phenotypes include an encephalomyopathic form with seizures and ataxia; a multisystem infantile form with encephalopathy, cardiomyopathy and renal failure; a predominantly cerebellar form with ataxia and cerebellar atrophy; Leigh syndrome with growth retardation; and an isolated myopathic form.

VIAS REACTOME (1)
OUTRAS DOENÇAS (1)
encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome
HGNC:25302UniProt:O75208
COQ24-hydroxybenzoate polyprenyltransferase, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Mediates the second step in the final reaction sequence of coenzyme Q (CoQ) biosynthesis (PubMed:15153069, PubMed:16400613, PubMed:17374725, PubMed:20526342). Catalyzes the prenylation of para-hydroxybenzoate (PHB) with an all-trans polyprenyl donor (such as all-trans-decaprenyl diphosphate) (PubMed:15153069, PubMed:16400613, PubMed:17374725, PubMed:20526342). The length of the polyprenyl side chain varies depending on the species, in humans, the side chain is comprised of 10 isoprenyls (decapre

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Ubiquinol biosynthesisMitochondrial protein import
MECANISMO DE DOENÇA

Coenzyme Q10 deficiency, primary, 1

An autosomal recessive disorder with variable manifestations consistent with 5 major phenotypes. The phenotypes include an encephalomyopathic form with seizures and ataxia; a multisystem infantile form with encephalopathy, cardiomyopathy and renal failure; a predominantly cerebellar form with ataxia and cerebellar atrophy; Leigh syndrome with growth retardation; and an isolated myopathic form.

OUTRAS DOENÇAS (4)
coenzyme Q10 deficiency, primary, 1multiple system atrophy, parkinsonian typemultiple system atrophy, cerebellar typemultiple system atrophy 1, susceptibility to
HGNC:25223UniProt:Q96H96

Variantes genéticas (ClinVar)

216 variantes patogênicas registradas no ClinVar.

🧬 COQ5: GRCh37/hg19 12q23.1-24.33(chr12:99532287-133777902)x3 ()
🧬 COQ5: GRCh37/hg19 12q24.21-24.33(chr12:116422123-133777902)x3 ()
🧬 COQ5: GRCh37/hg19 12q24.31(chr12:120829779-121489188)x1 ()
🧬 COQ5: GRCh37/hg19 12q24.22-24.33(chr12:117533207-133777902)x3 ()
🧬 COQ5: GRCh37/hg19 12q24.22-24.33(chr12:117533207-133777902)x3 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 217 variantes classificadas pelo ClinVar.

87
130
Patogênica (40.1%)
VUS (59.9%)
VARIANTES MAIS SIGNIFICATIVAS
COQ5: NM_032314.4(COQ5):c.133C>T (p.Gln45Ter) [Likely pathogenic]
COQ2: NM_001358921.2(COQ2):c.762+1del [Pathogenic]
COQ2: NM_001358921.2(COQ2):c.199G>C (p.Ala67Pro) [Likely pathogenic]
COQ2: NM_001358921.2(COQ2):c.367C>T (p.Arg123Cys) [Likely pathogenic]
COQ2: NM_015697.9(COQ2):c.40dup (p.Ala14fs) [Pathogenic]

Vias biológicas (Reactome)

2 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico4
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 4 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Deficiência de coenzima Q10

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

6 ensaios clínicos encontrados, 2 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
100 papers (10 anos)
#1

Coenzyme Q10 Supplementation in a Child with Biallelic COQ8A Variants: A Case Report.

Case reports in neurology2026

Pathogenic variants in COQ8A cause a rare form of primary coenzyme Q10 (CoQ10) deficiency that can lead to childhood-onset cerebellar ataxia and developmental delay. However, reports of pediatric cases remain limited, and evidence regarding therapeutic response to CoQ10 supplementation in children is still scarce. We report a 7-year-old boy with compound heterozygous COQ8A variants who presented with progressive cerebellar ataxia and intellectual disability. Oral CoQ10 supplementation was initiated at a dose of 10 mg/kg/day after institutional ethics approval. During 1 year of treatment, the Scale for the Assessment and Rating of Ataxia (SARA) score improved from 17 to 9, and serum CoQ10 concentration increased from 622 to 9.100 ng/mL. Mild cognitive improvement was also observed, with the intelligence quotient increasing from 53 to 64. Brain MRI demonstrated radiological stabilization of cerebellar atrophy. No adverse effects related to CoQ10 supplementation were observed throughout the treatment period. This case demonstrates the clinical benefit and safety of CoQ10 supplementation in pediatric-onset COQ8A-related ataxia. Early genetic diagnosis and timely initiation of CoQ10 therapy may lead to meaningful neurological improvement and stabilization of disease progression in affected children.

#2

Ferroptosis susceptibility in primary coenzyme Q10 deficiency: Cellular insights from patient fibroblasts and clinical course of six individuals.

Brain &amp; development2026 Feb

Primary coenzyme Q10 (CoQ10) deficiency is a group of mitochondrial disorders caused by pathogenic variants of genes involved in CoQ10 biosynthesis. Although some patients respond to oral CoQ10 supplementation, the pathophysiology remains poorly understood. Ferroptosis, a form of iron-dependent cell death driven by lipid peroxidation, is suppressed by reduced CoQ10via ferroptosis suppressor protein 1 (FSP1). However, its involvement in primary CoQ10 deficiency has not yet been studied using patient-derived cells. We reported six patients from three families and investigated ferroptosis susceptibility in fibroblasts from three representative patients: one with COQ2 variants and two with COQ4 variants. Fibroblasts with COQ2 variants showed increased vulnerability to ferroptosis inducers, plasma membrane lipid peroxidation. In contrast, fibroblasts with COQ4 variants exhibited only mild changes. Notably, susceptibility to ferroptosis remained unchanged after increasing intracellular CoQ10 levels. Despite this persistent ferroptosis sensitivity in vitro, the COQ2 patient exhibited significant clinical improvement following CoQ10 supplementation. These findings suggest that ferroptosis may contribute to cellular vulnerability in primary CoQ10 deficiency but may not be the primary driver of renal and neurological symptoms. Our results highlight a complex interplay between CoQ10 biosynthesis, ferroptosis defense, and therapeutic response, warranting further investigation of subcellular CoQ10 distribution and ferroptosis-related mechanisms.

#3

Clinical, genetic, and advanced neuroimaging features in adult siblings with Q10 deficiency due to COQ4 mutation: Review of literature.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026 Jan 13
#4

Mitochondrial Dysfunctions in Human Primary Coenzyme Q10 Deficiencies.

Biomolecules2026 Feb 14

Coenzyme Q10 (CoQ10) is an essential lipid-soluble molecule that plays a central role in mitochondrial energy production as a mobile electron carrier. In addition to its bioenergetic function, CoQ10 participates in antioxidant defense, redox homeostasis, lipid and nucleotide metabolism, and mitochondrial quality control. Primary CoQ10 deficiencies are rare inherited mitochondrial disorders caused by pathogenic variants in nuclear genes involved in CoQ10 biosynthesis. These defects lead to reduced CoQ10 levels and impaired mitochondrial functions. Clinically, primary CoQ10 deficiencies display remarkable phenotypic heterogeneity, ranging from isolated organ involvement, notably renal or cerebellar disease, to severe multisystemic disorders affecting the nervous system, skeletal muscle, heart, and other organs. Disease onset spans from the antenatal period to adulthood, and clinical severity varies widely, even among patients carrying variants in the same gene. This diversity cannot be fully explained by defective ATP production alone. Growing evidence indicates that disruption of non-bioenergetic functions of CoQ10, including oxidative stress regulation and CoQ-dependent metabolic pathways, contributes significantly to disease pathophysiology and tissue vulnerability. In this review, we summarize current knowledge on CoQ10 biology, biosynthesis, and the clinical spectrum of primary CoQ10 deficiencies, and we discuss emerging mechanisms linking CoQ10 depletion to mitochondrial dysfunctions and human diseases.

#5

Intermittent ketogenic fasting with medium-chain triglycerides improves ataxia in COQ8A-related coenzyme Q10 deficiency: A case report.

Molecular genetics and metabolism reports2026 Mar

Mutations in COQ8A cause primary coenzyme Q10 deficiency, which can present clinically heterogeneously: Symptoms range from cerebellar ataxia, epilepsy, encephalomyopathy, macular degeneration to nephropathy. High-dose coenzyme Q10 supplementation is widely used, yet there is little evidence on complementary strategies, particularly for non-epileptic features such as cerebellar ataxia. We report a 46-year-old female with genetically confirmed COQ8A-related coenzyme Q10 (CoQ10) deficiency, presenting with ataxia and epilepsy characterized by myoclonic and bilateral tonic-clonic seizures, who participated in a clinical protocol of ketogenic intermittent fasting, a method of intermittent fasting combined with medium-chain triglycerides (MCT) primarily designed for seizure management. The patient followed a 16:8 intermittent fasting regime combined with MCT intake for three months, followed by three months of all-alone intermittent fasting. Routine blood markers and brain MRI, including diffusion imaging were obtained before and after ketogenic fasting. During the study protocol, while no seizure reduction in myoclonic seizures could be observed, ataxia - quantified by the Scale for the Assessment and Rating of Ataxia (SARA) - improved significantly from 8.5 to 6.0 during the interventions. MRI showed a trend suggesting improved cerebellar microstructural integrity. This case highlights the potential of ketogenic intermittent fasting as an adjunct therapy for mitochondrial ataxia. Ketogenic intermittent fasting was associated with clinically meaningful improvement of ataxia in a patient with COQ8A-related CoQ10 deficiency, suggesting that ketogenic dietary strategies may represent a promising adjunct therapeutic approach for mitochondrial ataxia. Future research should assess this intervention in larger patient cohorts to confirm its potential benefits.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC114 artigos no totalmostrando 182

2026

Coenzyme Q10 Supplementation in a Child with Biallelic COQ8A Variants: A Case Report.

Case reports in neurology
2026

Mitochondrial Dysfunctions in Human Primary Coenzyme Q10 Deficiencies.

Biomolecules
2026

Intermittent ketogenic fasting with medium-chain triglycerides improves ataxia in COQ8A-related coenzyme Q10 deficiency: A case report.

Molecular genetics and metabolism reports
2025

Case Report: Myoclonic and tremulous movements associated with COQ8A-related coenzyme Q10 deficiency type 4.

Frontiers in genetics
2026

Clinical, genetic, and advanced neuroimaging features in adult siblings with Q10 deficiency due to COQ4 mutation: Review of literature.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

Ferroptosis susceptibility in primary coenzyme Q10 deficiency: Cellular insights from patient fibroblasts and clinical course of six individuals.

Brain &amp; development
2025

Successful Living Kidney Donation from Heterozygous Carrier Parents to Siblings with Coenzyme Q8B Nephropathy: Two Case Series.

Nephron
2025

Network Pharmacology Insights Into Statin-Induced Coenzyme Q10 Deficiency: Lipid Metabolic Crosstalk, TNF-MAPK Signaling, and Muscle Toxicity.

Lipids
2025

Prenatal Diagnosis of COQ2 Variants in Suspected Coenzyme Q10 Deficiency.

Kidney international reports
2025

Severe Neurological Presentation in Siblings With COQ5-Related Primary Coenzyme Q10 Deficiency: Expanding Clinical and Molecular Spectrum.

JIMD reports
2025

Mitochondrial redox imbalance and CoQ10 deficiency in Rett syndrome: Insights from patient-derived fibroblasts.

Archives of biochemistry and biophysics
2025

Fetal Anemia and Periventricular Hyperechogenicity/Halo as a Prenatal Indicator of CoQ10 Deficiency Associated With Biallelic Variant in COQ2 Gene.

Prenatal diagnosis
2025

CRISPR/Cas9-mediated editing of COQ4 in induced pluripotent stem cells: A model for investigating COQ4-associated human coenzyme Q10 deficiency.

Stem cell research
2025

Generation of an induced pluripotent stem cell (iPSC) line (XMUi001-A) derived from a patient harboring homozygous mutations c.370G > A (p.Gly124Ser) in the COQ4 gene.

Stem cell research
2025

Coenzyme Q headgroup intermediates can ameliorate a mitochondrial encephalopathy.

Nature
2025

Blended Phenotypes of Sexual Development Disorder and Coenzyme Q10 Deficiency, Together with a Sibling with Homozygous Variants in the AHI1 Gene.

Molecular syndromology
2025

A high-dose coenzyme Q10-emulgel for chronic oral therapy of deficient patients with secondary dysphagia.

Journal of pharmaceutical sciences
2025

Tremors with dystonia as a predominant manifestation of primary coenzyme Q10 deficiency.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Two cases of neonatal hyperglycemia caused by a homozygous COQ9 stop-gain variant.

Journal of diabetes investigation
2025

Modelling the human coenzyme Q deficiency in Drosophila melanogaster.

Free radical biology &amp; medicine
2025

Coenzyme Q10 deficiency disrupts lipid metabolism by altering cholesterol homeostasis in neurons.

Free radical biology &amp; medicine
2025

Identification of a new COQ4 spliceogenic variant causing severe primary coenzyme Q deficiency.

Molecular genetics and metabolism reports
2025

Syndromic retinitis pigmentosa.

Progress in retinal and eye research
2024

Adult-onset status epilepticus in patients with COQ8A coenzyme Q10 deficiency: A case series.

Epilepsy &amp; behavior reports
2024

[Diagnosis and treatment of primary coenzyme Q10 deficiency associated glomerulopathy].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2024

The Spectrum of clinical manifestations in newborns with the COQ4 mutation: case series and literature review.

Frontiers in pediatrics
2025

Familial thrombotic microangiopathy in a child with coenzyme Q10 deficiency-associated glomerulopathy.

Pediatric nephrology (Berlin, Germany)
2024

New variants expand the neurological phenotype of COQ7 deficiency.

Journal of inherited metabolic disease
2024

Alterations in coenzyme Q10 status in a cybrid line harboring the 3243A>G mutation of mitochondrial DNA is associated with abnormal mitochondrial bioenergetics and dysregulated mitochondrial biogenesis.

Biochimica et biophysica acta. Bioenergetics
2024

The Ubiquinone-Ubiquinol Redox Cycle and Its Clinical Consequences: An Overview.

International journal of molecular sciences
2024

The Effect of Neuronal CoQ10 Deficiency and Mitochondrial Dysfunction on a Rotenone-Induced Neuronal Cell Model of Parkinson's Disease.

International journal of molecular sciences
2024

Coenzyme Q deficiency may predispose to sudden unexplained death via an increased risk of cardiac arrhythmia.

International journal of legal medicine
2024

Glomerular basement membrane ultrastructural changes in a patient with COQ2 glomerulopathy: A case report.

Nephrology (Carlton, Vic.)
2024

Stroke-Like Lesions or Epiphenomena of Seizures in COQ8A -Related Coenzyme-Q10 Deficiency.

Annals of Indian Academy of Neurology
2024

COQ7 defect causes prenatal onset of mitochondrial CoQ10 deficiency with cardiomyopathy and gastrointestinal obstruction.

European journal of human genetics : EJHG
2024

4-Hydroxybenzoic acid rescues multisystemic disease and perinatal lethality in a mouse model of mitochondrial disease.

Cell reports
2024

Primary Coenzyme Q10 Deficiency-Related Ataxias.

Journal of clinical medicine
2024

Coenzyme Q4 is a functional substitute for coenzyme Q10 and can be targeted to the mitochondria.

The Journal of biological chemistry
2024

Primary Coenzyme Q10 Deficiency-4 Causing Young Onset Ataxia-Dystonia.

Movement disorders clinical practice
2024

Metabolic etiologies in children with infantile epileptic spasm syndrome: Experience at a tertiary pediatric neurology center.

Brain &amp; development
2024

Mitochondrial Dysfunction due to Novel COQ8A Variation with Poor Response to CoQ10 Treatment: A Comprehensive Study and Review of Literatures.

Cerebellum (London, England)
2024

Coenzyme Q deficiency in endothelial mitochondria caused by hypoxia; remodeling of the respiratory chain and sensitivity to anoxia/reoxygenation.

Free radical biology &amp; medicine
2024

Two Turkish patients with Primary Coenzyme Q10 Deficiency-7: case report and literature review.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2024

Mutations of GEMIN5 are associated with coenzyme Q10 deficiency: long-term follow-up after treatment.

European journal of human genetics : EJHG
2023

Stroke-Like Episodes and Epilepsy in a Patient with COQ8A-Related Coenzyme Q10 Deficiency.

Annals of Indian Academy of Neurology
2024

Brown adipose tissue CoQ deficiency activates the integrated stress response and FGF21-dependent mitohormesis.

The EMBO journal
2023

Epilepsy and Coenzyme Q10 deficiency with COQ4 variants.

Epilepsy &amp; behavior : E&amp;B
2023

Distal hereditary motor neuropathy caused by coenzyme Q deficiency due to COQ7 variants.

Brain : a journal of neurology
2023

Ataxia due to a COQ8A Novel Variant in Primary Coenzyme Q10 Deficiency.

Movement disorders clinical practice
2023

Primary Coenzyme Q10 Deficiency: An Update.

Antioxidants (Basel, Switzerland)
2023

Adolescence Onset Primary Coenzyme Q10 Deficiency With Rare CoQ8A Gene Mutation: A Case Report and Review of Literature.

Clinical medicine insights. Case reports
2023

Phenotypic, molecular, and functional characterization of COQ7-related primary CoQ10 deficiency: Hypomorphic variants and two distinct disease entities.

Molecular genetics and metabolism
2023

Biallelic variants in COQ7 cause distal hereditary motor neuropathy with upper motor neuron signs.

Brain : a journal of neurology
2023

Understanding the Pathogenesis of Cardiac Complications in Patients with Propionic Acidemia and Exploring Therapeutic Alternatives for Those Who Are Not Eligible or Are Waiting for Liver Transplantation.

Metabolites
2023

Characterization and bioavailability of a novel coenzyme Q10 nanoemulsion used as an infant formula supplement.

International journal of pharmaceutics
2023

Evaluation of Coenzyme Q10 (CoQ10) Deficiency and Therapy in Mouse Models of Cardiomyopathy.

Journal of cardiovascular pharmacology
2023

Total and reduced/oxidized forms of coenzyme Q10 in fibroblasts of patients with mitochondrial disease.

Molecular genetics and metabolism reports
2022

Depletion and Supplementation of Coenzyme Q10 in Secondary Deficiency Disorders.

Frontiers in bioscience (Landmark edition)
2023

Homozygous COQ7 mutation: a new cause of potentially treatable distal hereditary motor neuropathy.

Brain : a journal of neurology
2023

Retinopathy and optic atrophy in a case of COQ2-related primary coenzyme Q10 deficiency.

Ophthalmic genetics
2024

Coenzyme Q10 in aging and disease.

Critical reviews in food science and nutrition
2022

COQ8A-Ataxia as a Manifestation of Primary Coenzyme Q Deficiency.

Metabolites
2022

Manganese-driven CoQ deficiency.

Nature communications
2022

Reduced prosaposin levels in HepG2 cells with long-term coenzyme Q10 deficiency.

Journal of clinical biochemistry and nutrition
2022

Effects of CoQ10 Replacement Therapy on the Audiological Characteristics of Pediatric Patients with COQ6 Variants.

BioMed research international
2022

Treatable Ataxias: How to Find the Needle in the Haystack?

Journal of movement disorders
2022

Bi-Allelic COQ4 Variants Cause Adult-Onset Ataxia-Spasticity Spectrum Disease.

Movement disorders : official journal of the Movement Disorder Society
2022

The efficacy of coenzyme Q10 treatment in alleviating the symptoms of primary coenzyme Q10 deficiency: A systematic review.

Journal of cellular and molecular medicine
2022

Investigation of coenzyme Q10 status, serum amyloid-β, and tau protein in patients with dementia.

Frontiers in aging neuroscience
2022

Expanding the clinical spectrum of primary coenzyme Q10 deficiency type 6: The first case with cardiomyopathy.

Clinical genetics
2024

Primary CoQ10 deficiency with a severe phenotype due to the c.901 C > T (p.R301W) mutation in the COQ8A gene.

The International journal of neuroscience
2022

Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency.

Kidney international
2022

The cerebellar bioenergetic state predicts treatment response in COQ8A-related ataxia.

Parkinsonism &amp; related disorders
2022

Altered brown adipose tissue mitochondrial function in newborn fragile X syndrome mice.

Mitochondrion
2022

Variation of the clinical spectrum and genotype-phenotype associations in Coenzyme Q10 deficiency associated glomerulopathy.

Kidney international
2022

Coenzyme Q10 deficiency can be expected to compromise Sirt1 activity.

Open heart
2022

Epilepsia Partialis Continua a Clinical Feature of a Missense Variant in the ADCK3 Gene and Poor Response to Therapy.

Journal of molecular neuroscience : MN
2021

Primary Coenzyme Q10 Deficiency-7 and Pathogenic COQ4 Variants: Clinical Presentation, Biochemical Analyses, and Treatment.

Frontiers in genetics
2021

A Family Segregating Lethal Primary Coenzyme Q10 Deficiency Due to Two Novel COQ6 Variants.

Frontiers in genetics
2021

The Roles of Coenzyme Q in Disease: Direct and Indirect Involvement in Cellular Functions.

International journal of molecular sciences
2021

Cellular Models for Primary CoQ Deficiency Pathogenesis Study.

International journal of molecular sciences
2021

Coenzyme Q nanodisks counteract the effect of statins on C2C12 myotubes.

Nanomedicine : nanotechnology, biology, and medicine
2022

Unraveling the genetic complexities of combined retinal dystrophy and hearing impairment.

Human genetics
2021

Coenzyme Q10 supplementation - In ageing and disease.

Mechanisms of ageing and development
2021

Secondary CoQ10 deficiency, bioenergetics unbalance in disease and aging.

BioFactors (Oxford, England)
2021

Primary Coenzyme Q deficiencies: A literature review and online platform of clinical features to uncover genotype-phenotype correlations.

Free radical biology &amp; medicine
2021

Coenzyme Q10 deficiency in patients with hereditary hemochromatosis.

Clinics and research in hepatology and gastroenterology
2021

The multiple roles of coenzyme Q in cellular homeostasis and their relevance for the pathogenesis of coenzyme Q deficiency.

Free radical biology &amp; medicine
2021

Photoparoxysmal response in ADCK3 autosomal recessive ataxia: a case report and literature review.

Epileptic disorders : international epilepsy journal with videotape
2021

Coenzyme Q10 for Patients With Cardiovascular Disease: JACC Focus Seminar.

Journal of the American College of Cardiology
2021

Coenzyme Q10 for heart failure.

The Cochrane database of systematic reviews
2021

Secondary coenzyme Q deficiency in neurological disorders.

Free radical biology &amp; medicine
2021

Targeting a Braf/Mapk pathway rescues podocyte lipid peroxidation in CoQ-deficiency kidney disease.

The Journal of clinical investigation
2020

Redefining infantile-onset multisystem phenotypes of coenzyme Q10-deficiency in the next-generation sequencing era.

Journal of translational genetics and genomics
2020

Cellular Consequences of Coenzyme Q10 Deficiency in Neurodegeneration of the Retina and Brain.

International journal of molecular sciences
2021

Missense PDSS1 mutations in CoenzymeQ10 synthesis cause optic atrophy and sensorineural deafness.

Annals of clinical and translational neurology
2021

Clinical spectrum in multiple families with primary COQ10 deficiency.

American journal of medical genetics. Part A
2020

Compound heterozygous inheritance of two novel COQ2 variants results in familial coenzyme Q deficiency.

Orphanet journal of rare diseases
2020

Laboratory Diagnosis of a Case with Coenzyme Q10 Deficiency.

Clinical chemistry
2020

[Primary coenzyme Q10 deficiency-7: a case report and literature review].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2020

CoQ10 Deficient Endothelial Cell Culture Model for the Investigation of CoQ10 Blood-Brain Barrier Transport.

Journal of clinical medicine
2020

Coenzyme Q10 modulates sulfide metabolism and links the mitochondrial respiratory chain to pathways associated to one carbon metabolism.

Human molecular genetics
2021

Mitochondrial Disease and Coenzyme Q10 Deficiency: Commentary.

The Journal of pediatrics
2020

Disorders of Human Coenzyme Q10 Metabolism: An Overview.

International journal of molecular sciences
2021

Coenzyme Q biosynthesis inhibition induces HIF-1α stabilization and metabolic switch toward glycolysis.

The FEBS journal
2020

Mitochondrial energetic impairment in a patient with late-onset glutaric acidemia Type 2.

American journal of medical genetics. Part A
2020

Primary coenzyme Q10 deficiency due to COQ8A gene mutations.

Molecular genetics &amp; genomic medicine
2020

Early-onset coenzyme Q10 deficiency associated with ataxia and respiratory chain dysfunction due to novel pathogenic COQ8A variants, including a large intragenic deletion.

JIMD reports
2020

Metabolism of the Flavonol Kaempferol in Kidney Cells Liberates the B-ring to Enter Coenzyme Q Biosynthesis.

Molecules (Basel, Switzerland)
2020

A novel COQ8A missense variant associated with a mild form of primary coenzyme Q10 deficiency type 4.

Clinical biochemistry
2020

Clinical Evidence for Q10 Coenzyme Supplementation in Heart Failure: From Energetics to Functional Improvement.

Journal of clinical medicine
2020

Coenzyme Q10 Assessment and the Establishment of a Neuronal Cell Model of CoQ10 Deficiency.

Methods in molecular biology (Clifton, N.J.)
2020

Coenzyme Q10 status, glucose parameters, and antioxidative capacity in college athletes.

Journal of the International Society of Sports Nutrition
2020

A rare case of primary coenzyme Q10 deficiency due to COQ9 mutation.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2020

Design of High-Throughput Screening of Natural Extracts to Identify Molecules Bypassing Primary Coenzyme Q Deficiency in Saccharomyces cerevisiae.

SLAS discovery : advancing life sciences R &amp; D
2019

A steroid-resistant nephrotic syndrome in an infant resulting from a consanguineous marriage with COQ2 and ARSB gene mutations: a case report.

BMC medical genetics
2019

Dystonia-Ataxia with early handwriting deterioration in COQ8A mutation carriers: A case series and literature review.

Parkinsonism &amp; related disorders
2019

The Paradox of Coenzyme Q10 in Aging.

Nutrients
2020

Fetal coenzyme Q10 deficiency in intrahepatic cholestasis of pregnancy.

Clinics and research in hepatology and gastroenterology
2019

Primary coenzyme Q10 deficiency-7: expanded phenotypic spectrum and a founder mutation in southern Chinese.

NPJ genomic medicine
2019

Clinical whole-exome sequencing reveals a common pathogenic variant in patients with CoQ10 deficiency: An underdiagnosed cause of mitochondriopathy.

Clinica chimica acta; international journal of clinical chemistry
2019

Human COQ10A and COQ10B are distinct lipid-binding START domain proteins required for coenzyme Q function.

Journal of lipid research
2019

Vitamin K2 cannot substitute Coenzyme Q10 as electron carrier in the mitochondrial respiratory chain of mammalian cells.

Scientific reports
2019

Alterations of Mitochondrial Biology in the Oral Mucosa of Chilean Children with Autism Spectrum Disorder (ASD).

Cells
2019

Primary Coenzyme Q deficiency Due to Novel ADCK3 Variants, Studies in Fibroblasts and Review of Literature.

Neurochemical research
2019

Association between Crohn's disease and AarF domain-containing kinase 4 glomerulopathy.

Clinical journal of gastroenterology
2020

Primary coenzyme Q10 Deficiency-6 (COQ10D6): Two siblings with variable expressivity of the renal phenotype.

European journal of medical genetics
2019

Clinical phenotype, in silico and biomedical analyses, and intervention for an East Asian population-specific c.370G>A (p.G124S) COQ4 mutation in a Chinese family with CoQ10 deficiency-associated Leigh syndrome.

Journal of human genetics
2018

ADCK3-related Coenzyme Q10 Deficiency: A Potentially Treatable Genetic Disease.

Movement disorders clinical practice
2019

A study in a Polish ataxia cohort indicates genetic heterogeneity and points to MTCL1 as a novel candidate gene.

Clinical genetics
2018

Intracellular cholesterol accumulation and coenzyme Q10 deficiency in Familial Hypercholesterolemia.

Biochimica et biophysica acta. Molecular basis of disease
2018

Increased oxidative stress and coenzyme Q10 deficiency in centenarians.

Journal of clinical biochemistry and nutrition
2018

CoQ10 supplementation rescues nephrotic syndrome through normalization of H2S oxidation pathway.

Biochimica et biophysica acta. Molecular basis of disease
2018

CoQ10-related sustained remission of proteinuria in a child with COQ6 glomerulopathy-a case report.

Pediatric nephrology (Berlin, Germany)
2018

Coenzyme Q10 deficiency due to a COQ4 gene defect causes childhood-onset spinocerebellar ataxia and stroke-like episodes.

Molecular genetics and metabolism reports
2018

[Clinical analysis of one infantile nephrotic syndrome caused by COQ2 gene mutation and literature review].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2018

Clinical syndromes associated with Coenzyme Q10 deficiency.

Essays in biochemistry
2018

Coenzyme Q10 deficiencies: pathways in yeast and humans.

Essays in biochemistry
2018

Laboratory investigations.

Handbook of clinical neurology
2018

Molecular diagnosis of coenzyme Q10 deficiency: an update.

Expert review of molecular diagnostics
2018

The idebenone metabolite QS10 restores electron transfer in complex I and coenzyme Q defects.

Biochimica et biophysica acta. Bioenergetics
2018

COQ2 nephropathy: a treatable cause of nephrotic syndrome in children.

Pediatric nephrology (Berlin, Germany)
2018

A family segregating lethal neonatal coenzyme Q10 deficiency caused by mutations in COQ9.

Journal of inherited metabolic disease
2018

The dilemma of diagnosing coenzyme Q10 deficiency in muscle.

Molecular genetics and metabolism
2018

Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance.

eLife
2017

Estimating the occurrence of primary ubiquinone deficiency by analysis of large-scale sequencing data.

Scientific reports
2018

Bypassing human CoQ10 deficiency.

Molecular genetics and metabolism
2017

Transcriptomic and proteomic landscape of mitochondrial dysfunction reveals secondary coenzyme Q deficiency in mammals.

eLife
2018

Diffuse mesangial sclerosis in a PDSS2 mutation-induced coenzyme Q10 deficiency.

Pediatric nephrology (Berlin, Germany)
2017

Detection of 6-demethoxyubiquinone in CoQ10 deficiency disorders: Insights into enzyme interactions and identification of potential therapeutics.

Molecular genetics and metabolism
2017

Genetic Rescue of Mitochondrial and Skeletal Muscle Impairment in an Induced Pluripotent Stem Cells Model of Coenzyme Q10 Deficiency.

Stem cells (Dayton, Ohio)
2017

Focal segmental glomerulosclerosis and medullary nephrocalcinosis in children with ADCK4 mutations.

Pediatric nephrology (Berlin, Germany)
2017

The Value of Coenzyme Q10 Determination in Mitochondrial Patients.

Journal of clinical medicine
2017

[Primary coenzyme Q10 deficiency type 1 in nephrotic syndrome].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2017

COQ6 Mutations in Children With Steroid-Resistant Focal Segmental Glomerulosclerosis and Sensorineural Hearing Loss.

American journal of kidney diseases : the official journal of the National Kidney Foundation
2017

Further phenotypic heterogeneity of CoQ10 deficiency associated with steroid resistant nephrotic syndrome and novel COQ2 and COQ6 variants.

Clinical genetics
2016

Statins barely touch the heart but bite the kidneys after cardiac surgery. Coenzyme Q10 deficiency in the dock?

Annals of translational medicine
2017

CoQ deficiency causes disruption of mitochondrial sulfide oxidation, a new pathomechanism associated with this syndrome.

EMBO molecular medicine
2017

Coenzyme Q deficiency causes impairment of the sulfide oxidation pathway.

EMBO molecular medicine
2017

A Novel SUCLA2 Mutation Presenting as a Complex Childhood Movement Disorder.

Journal of child neurology
2016

The COQ2 genotype predicts the severity of coenzyme Q10 deficiency.

Human molecular genetics
2016

Atypical parkinsonism - new advances.

Current opinion in neurology
2016

Decreased Coenzyme Q10 Levels in Multiple System Atrophy Cerebellum.

Journal of neuropathology and experimental neurology
2016

Disruption of the human COQ5-containing protein complex is associated with diminished coenzyme Q10 levels under two different conditions of mitochondrial energy deficiency.

Biochimica et biophysica acta
2016

Genome-wide association study of serum coenzyme Q10 levels identifies susceptibility loci linked to neuronal diseases.

Human molecular genetics
2016

ADCK3 mutations with epilepsy, stroke-like episodes and ataxia: a POLG mimic?

European journal of neurology
2016

Coenzyme Q10 analytical determination in biological matrices and pharmaceuticals.

Frontiers in bioscience (Scholar edition)
2016

Coenzyme Q biosynthesis in health and disease.

Biochimica et biophysica acta
2016

Executive and Attentional Disorders, Epilepsy and Porencephalic Cyst in Autosomal Recessive Cerebellar Ataxia Type 3 Due to ANO10 Mutation.

European neurology
2016

Statin-associated cerebellar ataxia. A Brazilian case series.

Parkinsonism &amp; related disorders
2016

Cerebellar ataxia and severe muscle CoQ10 deficiency in a patient with a novel mutation in ADCK3.

Clinical genetics
2016

Coenzyme Q10 defects may be associated with a deficiency of Q10-independent mitochondrial respiratory chain complexes.

Biological research
2015

The Interaction Between Statins and Exercise: Mechanisms and Strategies to Counter the Musculoskeletal Side Effects of This Combination Therapy.

Ochsner journal
2016

MicroRNAs as biomarkers of hepatotoxicity in a randomized placebo-controlled study of simvastatin and ubiquinol supplementation.

Experimental biology and medicine (Maywood, N.J.)
2015

NOVEL MUTATION OF THE ELECTRON TRANSFERRING FLAVOPROTEIN DEHYDROGENASE (ETFDH) GENE IN THE ISOLATED MYOPATHIC FORM OF COENZYME q10 DEFICIENCY.

Genetic counseling (Geneva, Switzerland)
2015

Molecular diagnosis of coenzyme Q10 deficiency.

Expert review of molecular diagnostics
2015

Rescue of primary ubiquinone deficiency due to a novel COQ7 defect using 2,4-dihydroxybensoic acid.

Journal of medical genetics
2015

A novel non-invasive sampling method using buccal mucosa cells for determination of coenzyme Q10.

Analytical and bioanalytical chemistry
2015

The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene.

EMBO molecular medicine
2015

COQ4 mutations cause a broad spectrum of mitochondrial disorders associated with CoQ10 deficiency.

American journal of human genetics
2015

Dependence of brown adipose tissue function on CD36-mediated coenzyme Q uptake.

Cell reports
2015

Primary coenzyme Q10 deficiency presenting as fatal neonatal multiorgan failure.

European journal of human genetics : EJHG

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Deficiência de coenzima Q10.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Deficiência de coenzima Q10

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Coenzyme Q10 Supplementation in a Child with Biallelic COQ8A Variants: A Case Report.
    Case reports in neurology· 2026· PMID 41769026mais citado
  2. Ferroptosis susceptibility in primary coenzyme Q10 deficiency: Cellular insights from patient fibroblasts and clinical course of six individuals.
    Brain &amp; development· 2026· PMID 41468707mais citado
  3. Clinical, genetic, and advanced neuroimaging features in adult siblings with Q10 deficiency due to COQ4 mutation: Review of literature.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology· 2026· PMID 41528494mais citado
  4. Mitochondrial Dysfunctions in Human Primary Coenzyme Q10 Deficiencies.
    Biomolecules· 2026· PMID 41750371mais citado
  5. Intermittent ketogenic fasting with medium-chain triglycerides improves ataxia in COQ8A-related coenzyme Q10 deficiency: A case report.
    Molecular genetics and metabolism reports· 2026· PMID 41716779mais citado
  6. COQ8A-related Primary Coenzyme Q10 Deficiency Mimicking Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Syndrome: A Pediatric Case Report and Review of Mitochondrial Mimics.
    Ann Afr Med· 2026· PMID 41992454recente
  7. Case Report: Myoclonic and tremulous movements associated with COQ8A-related coenzyme Q10 deficiency type 4.
    Front Genet· 2025· PMID 41568333recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:35656(Orphanet)
  2. MONDO:0018151(MONDO)
  3. GARD:10423(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q5140809(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Deficiência de coenzima Q10
Compêndio · Raras BR

Deficiência de coenzima Q10

ORPHA:35656 · MONDO:0018151
Prevalência
Unknown
Herança
Autosomal recessive
CID-11
Ensaios
2 ativos
Início
All ages
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1843920
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades